High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer

NCT00002837 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: Filgrastim (G-CSF)
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Paclitaxel
PROCEDURE: Peripheral Blood Stem Cell Transplantation

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]